Redeye makes negligible estimate revisions on the back of I-Tech’s strong Q3-figures, posting organic growth of 48% while growing EBIT by 69%. The regulatory process continues to color the share price sentiment, even though I-Tech has performed financially. The financial outlook remains promising with two potential product launches in the next 6-12 months.
LÄS MER